FI860010L - Basiska produkter av kinolonkarboxylsyror. - Google Patents
Basiska produkter av kinolonkarboxylsyror. Download PDFInfo
- Publication number
- FI860010L FI860010L FI860010A FI860010A FI860010L FI 860010 L FI860010 L FI 860010L FI 860010 A FI860010 A FI 860010A FI 860010 A FI860010 A FI 860010A FI 860010 L FI860010 L FI 860010L
- Authority
- FI
- Finland
- Prior art keywords
- kinolonkarboxylsyror
- basiska
- produkter
- basiska produkter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Silicon Polymers (AREA)
- Noodles (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3500243 | 1985-01-05 | ||
| DE3500243 | 1985-01-05 | ||
| DE19853517709 DE3517709A1 (de) | 1985-01-05 | 1985-05-17 | Basische zubereitungen von chinoloncarbonsaeuren |
| DE3517709 | 1985-05-17 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI860010A0 FI860010A0 (fi) | 1986-01-02 |
| FI860010L true FI860010L (fi) | 1986-07-06 |
| FI87425B FI87425B (fi) | 1992-09-30 |
| FI87425C FI87425C (fi) | 1993-01-11 |
Family
ID=25828371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI860010A FI87425C (fi) | 1985-01-05 | 1986-01-02 | Foerfarande foer framstaellning av infusions- eller injektionsloesningar av 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl- eller 4-etyl-1-piperazinyl)-3-kinolinkarboxylsyra |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4772605A (fi) |
| EP (1) | EP0187315B1 (fi) |
| KR (1) | KR890002240B1 (fi) |
| CN (2) | CN1011572B (fi) |
| AT (1) | ATE62595T1 (fi) |
| AU (1) | AU563777B2 (fi) |
| CA (1) | CA1273578A (fi) |
| DE (2) | DE3517709A1 (fi) |
| DK (1) | DK165666C (fi) |
| ES (3) | ES8802423A1 (fi) |
| FI (1) | FI87425C (fi) |
| GR (1) | GR860008B (fi) |
| HU (1) | HU194735B (fi) |
| IE (1) | IE58450B1 (fi) |
| IL (1) | IL77506A (fi) |
| NO (1) | NO172674C (fi) |
| PH (1) | PH25649A (fi) |
| PT (1) | PT81792B (fi) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
| JPH0696533B2 (ja) * | 1987-01-14 | 1994-11-30 | 北陸製薬株式会社 | キノロンカルボン酸の水性組成物 |
| JPH01175935A (ja) * | 1987-12-28 | 1989-07-12 | Kyorin Pharmaceut Co Ltd | 凍結乾燥注射剤 |
| JPH0228178A (ja) * | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
| DE3902079A1 (de) * | 1988-04-15 | 1989-10-26 | Bayer Ag | I.m. injektionsformen von gyrase-inhibitoren |
| US5225413A (en) * | 1988-09-16 | 1993-07-06 | Bayer-Aktiengesellschaft | pH-neutral aqueous solutions of quinolone-carboxylic acids |
| US4978661A (en) * | 1988-09-29 | 1990-12-18 | Innocenzo Caruso | Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis |
| US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
| FR2655545B1 (fr) * | 1989-12-11 | 1994-06-10 | Rhone Poulenc Sante | Nouvelle application therapeutique des derives des fluoroquinolones. |
| US5084276A (en) * | 1990-01-05 | 1992-01-28 | Abbott Laboratories | Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation |
| KR0159540B1 (ko) * | 1992-01-21 | 1998-12-01 | 김정순 | 퀴놀론-카복실산의 염 및 그 함유조성물 |
| IT1270836B (it) * | 1993-10-27 | 1997-05-13 | Archimica Spa | Procedimento per la preparazione di rufloxacina e suoi sali |
| DE69618987T2 (de) * | 1995-12-21 | 2002-11-21 | Pfizer Inc., New York | Injizierbare quinolonformulierungen |
| IN186245B (fi) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
| ID21415A (id) | 1997-12-05 | 1999-06-10 | Upjohn Co | Senyawa-senyawa antibiotik magnesium quinolon |
| ATE404561T1 (de) * | 2001-04-17 | 2008-08-15 | Dainippon Sumitomo Pharma Co | Neue adeninderivate |
| US6872723B2 (en) * | 2002-01-28 | 2005-03-29 | Wyeth | Stabilized difloxacin injectable solution |
| EP1572190B1 (en) * | 2002-12-17 | 2007-04-18 | Abbott GmbH & Co. KG | Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| US20080051411A1 (en) * | 2002-12-17 | 2008-02-28 | Cink Russell D | Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof |
| US20060073117A1 (en) * | 2004-10-01 | 2006-04-06 | Stowers Institute For Medical Research | Methods and compositions for controlling hair follicle stem cell fate |
| DE102004054873A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Healthcare Ag | Behandlung von Mastitis |
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| GB2480276A (en) * | 2010-05-11 | 2011-11-16 | Michael Hilary Burke | Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation |
| EP2621491B1 (en) | 2010-09-27 | 2018-08-29 | Emergent Product Development Gaithersburg Inc. | 2-pyridone antimicrobial compositions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2953974C2 (fi) * | 1978-04-12 | 1992-06-25 | Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp | |
| JPS6019910B2 (ja) * | 1979-10-11 | 1985-05-18 | 大塚製薬株式会社 | ベンゾ〔ij〕キノリジン−2−カルボン酸誘導体及びその製造法 |
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
| JPS5551422A (en) * | 1978-10-11 | 1980-04-15 | Takeda Chem Ind Ltd | Deodorization |
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| DE3033157A1 (de) * | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| US4404197A (en) * | 1981-05-15 | 1983-09-13 | Fox Jr Charles L | Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof and silver sulfadiazine |
| ES8304117A1 (es) * | 1981-06-11 | 1983-02-16 | Warner Lambert Co | "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". |
| DE3225367A1 (de) * | 1982-07-07 | 1984-01-12 | Hoechst Ag, 6230 Frankfurt | Arzneimittel zur behandlung von infektioes bedingten diarrhoeen |
| US4551456A (en) * | 1983-11-14 | 1985-11-05 | Merck & Co., Inc. | Ophthalmic use of norfloxacin and related antibiotics |
-
1985
- 1985-05-17 DE DE19853517709 patent/DE3517709A1/de not_active Withdrawn
- 1985-12-10 AU AU51046/85A patent/AU563777B2/en not_active Expired
- 1985-12-14 DE DE8585116001T patent/DE3582575D1/de not_active Expired - Lifetime
- 1985-12-14 EP EP85116001A patent/EP0187315B1/de not_active Expired - Lifetime
- 1985-12-14 AT AT85116001T patent/ATE62595T1/de not_active IP Right Cessation
- 1985-12-17 NO NO855094A patent/NO172674C/no not_active IP Right Cessation
- 1985-12-30 KR KR1019850009974A patent/KR890002240B1/ko not_active Expired
- 1985-12-31 CN CN85109451A patent/CN1011572B/zh not_active Expired
-
1986
- 1986-01-02 FI FI860010A patent/FI87425C/fi not_active IP Right Cessation
- 1986-01-02 IL IL77506A patent/IL77506A/xx not_active IP Right Cessation
- 1986-01-03 ES ES550668A patent/ES8802423A1/es not_active Expired
- 1986-01-03 PT PT81792A patent/PT81792B/pt unknown
- 1986-01-03 IE IE1886A patent/IE58450B1/en not_active IP Right Cessation
- 1986-01-03 GR GR860008A patent/GR860008B/el not_active IP Right Cessation
- 1986-01-03 CA CA000498934A patent/CA1273578A/en not_active Expired - Lifetime
- 1986-01-03 DK DK002386A patent/DK165666C/da not_active IP Right Cessation
- 1986-01-03 PH PH33258A patent/PH25649A/en unknown
- 1986-01-03 HU HU8622A patent/HU194735B/hu active IP Right Maintenance
-
1987
- 1987-09-14 US US07/097,017 patent/US4772605A/en not_active Expired - Lifetime
- 1987-10-16 ES ES557770A patent/ES8900196A1/es not_active Expired
- 1987-10-16 ES ES557771A patent/ES8802150A1/es not_active Expired
-
1989
- 1989-07-29 CN CN89105491A patent/CN1040143A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI862008L (fi) | Absorberande produkter foer engaongsbruk. | |
| FI862586A7 (fi) | Hydrogelbildande polymerkompositioner foer anvaendning i absorberande produkter. | |
| FI850004L (fi) | Foerfarande foer identifiering av nukleinsyror. | |
| FI872114A7 (fi) | Foerfarande foer tryckning av formade produkter haerledda fraon aramidfibrer. | |
| FI861223L (fi) | Belagda aoterhaemtningsbara produkter. | |
| FI860010L (fi) | Basiska produkter av kinolonkarboxylsyror. | |
| FI870701A0 (fi) | Anordning foer avvaegd dosering av granulaera eller pulverformiga produkter. | |
| FI872187A0 (fi) | Reningsfoerfarande med syra foer produkter av rostfritt staol. | |
| FI850090A0 (fi) | Foerfarande foer framstaellning av naturstensimitationer. | |
| FI891559A0 (fi) | Foerfarande foer framstaellning av lignocellulosamaterialfibrer innehaollande produkter. | |
| FI865100L (fi) | Foerfarande foer blekning och delignifiering av cellulosahaltiga produkter. | |
| FI872132L (fi) | Framstaellning av koettbaserade produkter. | |
| FI850612A0 (fi) | Behaollare foer infrysning av laett foerstoerbara produkter. | |
| FI872458A0 (fi) | Oeverdragning av produkter. | |
| FI881331A7 (fi) | Foerfarande foer avskiljande av oeverlappsvis transporterade produkter. | |
| FI871183A0 (fi) | Magnetiseringsanordning foer magnetografisk inspektion av produkter. | |
| FI850208L (fi) | Foerfarande foer styrning av alkaliska cellulosakok. | |
| FI861293A0 (fi) | Kompaktfoerpackning foer spridbara produkter. | |
| FI871904L (fi) | Foerpackning foer sterila produkter. | |
| FI861419A0 (fi) | Foerfarande vid tillverkning av produkter innehaollande traespaon. | |
| FI870572A0 (fi) | Nytt foerfarande foer framstaellning av keramiska produkter. | |
| FI872869L (fi) | Foerfarande foer stabilisering av enzymet laktoperoxidas i produkter. | |
| FI862225A0 (fi) | Foerfarande foer framstaellning av tvaerbundna produkter haerledda fraon omaettade uretaner. | |
| FI853563A0 (fi) | Foerfarande foer framstaellning av vattenavstoetande produkter av gips. | |
| FI863205A0 (fi) | Anordning foer saenkning av roerliknande produkter. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: BAYER AKTIENGESELLSCHAFT |
|
| MA | Patent expired |